Birmingham Ear Clinic Limited 08324577 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is diagnosis and treatment of ear, hearing and balance problems in adults and children. Digita Accounts Production Advanced 6.30.9574.0 true 08324577 2024-01-01 2024-12-31 08324577 2024-12-31 08324577 core:RetainedEarningsAccumulatedLosses 2024-12-31 08324577 core:ShareCapital 2024-12-31 08324577 core:CurrentFinancialInstruments 2024-12-31 08324577 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08324577 core:Non-currentFinancialInstruments 2024-12-31 08324577 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 08324577 core:OtherPropertyPlantEquipment 2024-12-31 08324577 bus:SmallEntities 2024-01-01 2024-12-31 08324577 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 08324577 bus:FilletedAccounts 2024-01-01 2024-12-31 08324577 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08324577 bus:RegisteredOffice 2024-01-01 2024-12-31 08324577 bus:Director1 2024-01-01 2024-12-31 08324577 bus:Director2 2024-01-01 2024-12-31 08324577 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08324577 core:ComputerEquipment 2024-01-01 2024-12-31 08324577 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 08324577 countries:EnglandWales 2024-01-01 2024-12-31 08324577 2023-12-31 08324577 core:OtherPropertyPlantEquipment 2023-12-31 08324577 2023-01-01 2023-12-31 08324577 2023-12-31 08324577 core:RetainedEarningsAccumulatedLosses 2023-12-31 08324577 core:ShareCapital 2023-12-31 08324577 core:CurrentFinancialInstruments 2023-12-31 08324577 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 08324577 core:Non-currentFinancialInstruments 2023-12-31 08324577 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 08324577 core:OtherPropertyPlantEquipment 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 08324577

Birmingham Ear Clinic Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Birmingham Ear Clinic Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 7

 

Birmingham Ear Clinic Limited

Company Information

Directors

Mr R M Irving

Mrs J L Irving

Registered office

Oakmoore Court
11c Kingswood Road
Droitwich
Worcs
WR9 0QH

Accountants

Ballards LLP
Chartered Accountants
Oakmoore Court
11C Kingswood Road
Hampton Lovett
Droitwich
Worcestershire
WR9 0QH

 

Birmingham Ear Clinic Limited

(Registration number: 08324577)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

3

1,897

765

Current assets

 

Debtors

4

19,177

27,525

Cash at bank and in hand

 

18,657

9,285

 

37,834

36,810

Creditors: Amounts falling due within one year

5

(21,962)

(22,874)

Net current assets

 

15,872

13,936

Total assets less current liabilities

 

17,769

14,701

Creditors: Amounts falling due after more than one year

5

(3,972)

(12,945)

Provisions for liabilities

(360)

(145)

Net assets

 

13,437

1,611

Capital and reserves

 

Called up share capital

100

100

Retained earnings

13,337

1,511

Shareholders' funds

 

13,437

1,611

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 February 2025 and signed on its behalf by:
 

.........................................
Mr R M Irving
Director

.........................................
Mrs J L Irving
Director

 
     
 

Birmingham Ear Clinic Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

1

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the Company’s activities. Turnover represents net invoiced sales of services, excluding value added tax.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Birmingham Ear Clinic Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

33.3% on cost

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Birmingham Ear Clinic Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 2).

 

Birmingham Ear Clinic Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

3

Tangible assets

Other property, plant and equipment
 £

Total
£

Cost or valuation

At 1 January 2024

15,088

15,088

Additions

1,605

1,605

At 31 December 2024

16,693

16,693

Depreciation

At 1 January 2024

14,323

14,323

Charge for the year

473

473

At 31 December 2024

14,796

14,796

Carrying amount

At 31 December 2024

1,897

1,897

At 31 December 2023

765

765

4

Debtors

Current

2024
£

2023
£

Trade debtors

10,618

16,141

Prepayments

4,225

5,951

Other debtors

4,334

5,433

 

19,177

27,525

5

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

6

9,137

9,137

Trade creditors

 

3,810

6,740

Taxation and social security

 

3,035

1,368

Accruals and deferred income

 

5,980

5,629

 

21,962

22,874

 

Birmingham Ear Clinic Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

6

3,972

12,945

6

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

3,972

12,945

Current loans and borrowings

2024
£

2023
£

Bank borrowings

9,137

9,137